Real-time enrollment status for this resectable hepatocellular carcinoma clinical trial
Current Status
Recruiting
Checked: July 17, 2026 at 10:20 PM UTC
| NCT Number | NCT05701488 |
| Recruiting Status | Recruiting |
| Condition | Resectable Hepatocellular Carcinoma |
| Phase | PHASE1 |
| Target Enrollment | 20 participants |
| Active Locations | 3 sites in the US |
| Sponsor | Jiping Wang, MD, PhD |
| Last Updated on CT.gov | September 2, 2025 (Sep 2, 2025) |
As of July 17, 2026: Clinical trial NCT05701488 is currently recruiting participants. This phase1 study for resectable hepatocellular carcinoma is actively seeking new participants at 3 locations across the United States. The study is sponsored by Jiping Wang, MD, PhD. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05701488 is actively recruiting participants as of July 17, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 3 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05701488 was last updated Sep 2, 2025 (September 2, 2025). HelloStudys verifies this status automatically.